SCHEMBL7568648

SCHEMBL7568648

ClC(COBOCC(Cl)OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
SLC1A3 P43003 2/20 0.38
SLC1A2 P43004 2/20 0.38
SLC1A1 P43005 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
IDO1 P14902 1/20 0.38
AGXT P21549 1/20 0.36
CA1 P00915 5/20 0.36
CA2 P00918 3/20 0.36
CA9 Q16790 3/20 0.36
ALDH1A1 P00352 1/20 0.36
CA7 P43166 2/20 0.36
SLC6A2 P23975 3/20 0.36
SLC6A3 Q01959 3/20 0.36
SLC6A4 P31645 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10967299 0.76 TSHR (0.43) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL14667806 0.76 TSHR (0.46) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL1456871 0.75 TSHR (0.44) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL10965779 0.75 TSHR (0.44) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL10344292 0.73 TSHR (0.52) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL723193 0.73 TSHR (0.57) TSHRKMT2ACYP1A2CYP2C19IDO1
SCHEMBL8815544 0.72 SLC1A3 (0.42) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL8114209 0.72 PPARG (0.42) TSHRSLC1A3SLC1A2SLC1A1KMT2A
SCHEMBL2861614 0.71 KMT2A (0.62) SLC1A3SLC1A2SLC1A1KMT2AMEN1
SCHEMBL14998980 0.70 TSHR (0.40) TSHRSLC1A3SLC1A2SLC1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206449-A1 LACTAM INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB COMPANY (US) 2002-05-22 EP disclosed
EP-1196436-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE Bristol-Myers Squibb Pharma Company (US) 2002-04-17 EP disclosed
WO-2001007407-A1 LACTAM INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-02-01 WO disclosed
WO-2001002424-A2 PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE DU PONT PHARMACEUTICALS COMPANY (US) 2001-01-11 WO disclosed